Company Filing History:
Years Active: 2020-2025
Title: Gregory Burshtein: Innovator in Pharmaceutical Compositions
Introduction
Gregory Burshtein is a notable inventor based in Modiin, Israel. He has made significant contributions to the field of pharmaceutical compositions, particularly in formulations for oral administration of active agents. With a total of 3 patents, Burshtein's work focuses on enhancing the efficacy of therapeutically active agents.
Latest Patents
Burshtein's latest patents include innovative formulations that combine active agents with absorption enhancers. One of his notable inventions is a pharmaceutical composition that comprises a therapeutically active agent and an absorption enhancer such as NAC, NAD, 5-CNAC, 4-MOAC, or 4-CNAB. This composition is designed for the treatment of conditions that can be addressed by the active agent. Additionally, he has developed multi-dose compositions that allow for the concomitant oral administration of multiple unit dosage forms, ensuring a therapeutically effective amount of both the active agent and the absorption enhancer. Another significant patent involves a composition that includes SNAC and at least one antacid compound, aimed at improving the oral administration of therapeutically active agents.
Career Highlights
Gregory Burshtein is currently associated with Entera Bio Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new methods for oral drug delivery, which can significantly impact patient treatment outcomes.
Collaborations
Burshtein collaborates with esteemed colleagues such as Ariel Rothner and Phillip M Schwartz, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.
Conclusion
Gregory Burshtein's contributions to pharmaceutical compositions highlight his role as a key innovator in the field. His patents reflect a commitment to improving drug delivery methods, ultimately benefiting patient care.